Aninion, Florante G.
HRN: 24-07-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
CEFTRIAXONE 1G (VIAL)
11/12/2023
11/19/2023
IV
1
Q8
Soft Tissue Infection Immunodeficiency
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes